Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 11, 2024

Real-world Outcomes of Diffuse Large B-cell Lymphoma Treated with frontline R-CHOP(-like) regimens in an Asian Multi-ethnic Population

View Full Paper
Ask AI
Bookmark
Share

Authors

RLRyan Mao Heng LimJTJing Yuan TanYTYa Hwee Tan

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lim et al. (2024) studied this question.

synapsesocial.com/papers/68e58ddab6db6435875293b3https://doi.org/10.21203/rs.3.rs-4855200/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Outcomes in relapsed/refractory diffuse large B-cell lymphoma in an Asian tertiary cancer center: contemporary interventions as a benchmark for novel therapy2025
  2. 2Long-term outcomes, survival predictors and up-front treatment patterns in 568 elderly diffuse large b-cell lymphoma patients from LATAM: Is R-CHOP still the first choice for treating patients older than 60 years?2025
  3. 3Frequency of Complete Remission With R-CHOP Therapy in Patients With Diffuse Large B Cell Lymphoma2024 · 1 citations
  4. 4Treatment of Diffuse Large B-Cell Lymphoma at the Moscow City Clinical Hospital No. 52: A Retrospective Clinical Trial Based on the Single-Center Experience and Analysis of Data from Its In-House Registry2024
  5. 5Real‐world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B‐cell lymphoma by line of therapy2024 · 18 citations